001060 JW중외제약

기본 정보

  • 섹터: KOSPI:제약
  • 시가총액: 5,984억원 (2026-06-30 기준)
  • 첫 등장: 2026-06-29 (누적 1일)
  • 태그: 매크로/IT소프트웨어 · 매크로/바이오헬스 · 제약 · 전문의약품 · 순환기 · 내분비 · AI
  • 네이버 금융: 🔗

기업개요

  • 동사는 1945년 ‘조선중외제약소’로 출범해 1953년 ‘대한중외제약 주식회사’로 법인을 설립하고, 1976년 기업공개를 통해 유가증권시장에 상장하였음.
  • 2019년 베트남 Euvipharm社를 100% 인수하며 이머징 시장으로 사업영역을 확장하였음.
  • 동사는 의약품의 연구, 개발, 제조, 판매를 주요 사업으로 하며, 리바로, 헴리브라, 트루패스, 악템라 등 오리지널 파이프라인과 3세대 3챔버 영양수액 위너프를 보유하고 있음.

출처: 네이버증권 종목분석 (WiseReport)

일자별 등장 (최신 위, 누적)

일자전일 종가종가등락률시간외vol색깔smart금투그외
2026-08-1428,95028,550🔵 -1.38%-1.03%p×1.8🔻 개인-10.0억-9.8-0.2+0.1-0.0+6.8+3.1
2026-08-1330,00028,950🔵 -3.50%+1.50%p×2.7🔻 개인-15.8억-19.0+3.2-0.1+0.0+17.1-1.2
2026-08-1229,55030,000🔴 +1.52%+0.00%p×13.4🔻 개인-35.4억-42.3+6.8+0.1+0.1+31.1+4.3
2026-08-1125,70029,550➕ 🔴 +14.98%+12.84%p ⚡×1.1🟢 외인+0.4억+0.4+0.0+0.1-0.0-0.5+0.0
2026-08-1024,90025,700🔴 +3.21%+0.00%p×1.0🟢 외인+0.7억+1.1-0.5+0.0+0.0-0.6-0.1
2026-08-0724,65024,900🔴 +1.01%+0.00%p×0.8🟢 외인+2.3억+2.3+0.0-0.0+0.0-2.3+0.0
2026-08-0624,20024,650🔴 +1.86%+0.21%p×1.0🟢 외인+0.2억+0.2+0.1+0.1+0.0+0.1-0.5
2026-08-0524,15024,200🔴 +0.21%-0.62%p×0.8🟢 외인+1.2억+1.2+0.0-0.0-0.0-1.1-0.1
2026-08-0423,05024,150🔴 +4.77%-0.22%p×0.9🟢 외인+1.6억+1.6+0.0-0.1+0.0-1.5+0.1
2026-08-0323,50023,050🔵 -1.91%-0.63%p×0.6🔻 개인-0.8억-0.8+0.0+0.1+0.0+0.6+0.1
2026-07-3122,50023,500🔴 +4.44%+0.00%p×0.8🟢 외인+0.3억+0.3-0.2-0.2+0.2-0.1+0.0
2026-07-3022,10022,500🔴 +1.81%-0.45%p×1.0🟢 외인+4.7억+4.7+0.0-0.2+0.0-4.5+0.0
2026-07-2923,00022,100🔵 -3.91%+0.44%p×2.1🟢 외인+1.3억+1.4-0.0+0.1-0.0-0.9-0.5
2026-07-2824,10023,000🔵 -4.56%-0.41%p×1.3🔻 개인-2.1억-2.0-0.0+0.1-0.0+1.9+0.0
2026-07-2724,00024,100🔴 +0.42%+0.42%p×0.4🔻 개인-0.8억-0.8+0.0-0.0+0.0+0.8+0.0
2026-07-2424,10024,000🔵 -0.41%-0.62%p×1.2🟢 외인+0.9억+1.1+0.0+0.1-0.2-0.8-0.2
2026-07-2323,50024,100🔴 +2.55%+0.00%p×0.9🟢 외인+3.0억+3.5-0.9-0.0+0.4-3.0+0.0
2026-07-2223,75023,500🔵 -1.05%+0.42%p×0.7🔻 개인-0.9억-0.9+0.0-0.0-0.0+0.9+0.0
2026-07-2123,70023,750🔴 +0.21%+0.21%p×0.7🟢 외인+0.6억+0.6+0.0-0.1+0.0-0.5+0.0
2026-07-2024,30023,700🔵 -2.47%+1.44%p×0.7🔻 개인-1.9억-1.9+0.0+0.0+0.0+1.9+0.0
2026-07-1624,35024,300🔵 -0.21%+0.20%p×0.7🔻 개인-0.6억-0.6+0.0+0.0+0.0+0.7-0.1
2026-07-1523,75024,350🔴 +2.53%+0.42%p×0.5🟢 외인+2.3억+2.3+0.0-0.1+0.0-2.2-0.0
2026-07-1424,05023,750🔵 -1.25%+1.24%p×1.4🔻 개인-1.3억-1.8+0.4-0.0+0.0+2.0-0.7
2026-07-1325,00024,050🔵 -3.80%+0.20%p×0.6🔻 개인-0.7억-0.7-0.0+0.0+0.0+0.7+0.0
2026-07-1023,60025,000🔴 +5.93%+0.00%p×0.7🟢 외인+3.9억+3.8+0.0-0.2+0.1-3.6-0.1
2026-07-0923,75023,600🔵 -0.63%-0.42%p×1.0🟢 외인+4.4억+4.1+0.2+0.0+0.0-4.5+0.1
2026-07-0825,20023,750🔵 -5.75%-1.38%p×0.7🟢 외인+3.0억+3.0+0.0-0.4-0.0-2.5-0.1
2026-07-0725,30025,200🔵 -0.40%-0.60%p×0.8🟢 외인+1.1억+1.1+0.0+0.1+0.0-1.2+0.0
2026-07-0625,90025,300🔵 -2.32%+0.00%p×0.5🔻 개인+0.0억+0.0+0.0+0.0+0.0+0.5-0.6
2026-07-0325,75025,900🔴 +0.39%+0.00%p×1.0🟢 외인+3.1억+3.1+0.0+0.0-0.0-3.1-0.1
2026-07-0226,00025,750🔵 -0.96%-0.19%p×0.5🔻 개인-1.2억-1.2+0.0+0.1+0.0+1.0+0.1
2026-07-0125,65026,000🔴 +1.36%+0.00%p×0.7⚫ 그외+1.4억-1.1+2.5+0.0+0.0-4.4+3.0
2026-06-3026,30025,650🔵 -2.47%-0.19%p×0.5🔻 개인-2.0억-2.4+0.3-0.1+0.1+2.0+0.1
2026-06-2923,70026,300🔴 +10.97%-0.21%p×1.2🟢 외인+10.4억+11.0-0.6+0.0+0.0-10.2-0.2
2026-06-2625,00023,700🔵 -5.20%-1.60%p×1.5🟢 외인+7.2억+7.8-0.6+0.1+0.0-8.3+1.0
2026-06-2525,90025,000🔵 -3.47%-0.96%p×0.6🟢 외인+0.3억+0.5+0.0+0.1-0.2-0.6+0.1
2026-06-2424,55025,900🔴 +5.50%-0.20%p×0.7🟢 외인+2.4억+2.4+0.0+0.1-0.0-2.5+0.0
2026-06-2325,65024,550🔵 -4.29%-1.76%p×1.6🟢 외인+2.8억+2.3+0.5+0.1-3.1+0.2
2026-06-2226,85025,650🔵 -4.47%-0.19%p×1.0🟢 외인+4.7억+4.7+0.0-0.2-1.4-3.2
2026-06-1927,05026,850🔵 -0.74%+0.55%p×1.3🟦 연기금+4.5억+1.1+3.4-0.2-4.0-0.3
2026-06-1828,15027,050🔵 -3.91%-0.71%p×0.6🟦 연기금+0.6억-1.6+2.2-0.2-1.0+0.6
2026-06-1727,30028,150🔴 +3.11%+0.91%p×1.0🟢 외인+1.7억+2.0-0.3-0.1-1.6+0.0
2026-06-1628,20027,300🔵 -3.19%+0.18%p×0.7🟢 외인+1.1억+0.8+0.3-0.1-0.8-0.1
2026-06-1526,90028,200🔴 +4.83%+0.55%p×1.4🔻 개인-9.5억-9.5+0.0-0.2+9.1+0.6
2026-06-1226,75026,900🔴 +0.56%-0.56%p×0.8🟡 금투+0.0억+0.0+0.0+0.2-0.2-0.1
2026-06-1125,90026,750🔴 +3.28%+0.96%p×0.8⚫ 그외-0.8억-0.3-0.6+0.1-0.4+1.2
2026-06-1026,15025,900🔵 -0.96%-1.72%p×0.5🔻 개인-0.5억-0.8+0.3+0.1+0.4-0.0
2026-06-0924,25026,150🔴 +7.84%+0.21%p×0.8🟢 외인+2.9억+3.1-0.2-0.0-2.6-0.2
2026-06-0826,00024,250🔵 -6.73%-0.77%p×1.2🟢 외인+5.6억+5.9-0.2+0.1-6.7+1.0
2026-06-0526,00026,000⚪ +0.00%+0.00%p×0.8🟡 금투-0.4억-0.4+0.0+0.2+0.2+0.0
2026-06-0427,05026,000🔵 -3.88%-0.55%p×1.1⚫ 그외+0.3억+0.3+0.0+0.1-4.5+4.0
2026-06-0227,10027,050🔵 -0.18%+0.56%p×0.9🟢 외인+5.4억+5.7-0.3+0.2-5.8+0.2
2026-06-0127,80027,100🔵 -2.52%+0.18%p×1.4🟢 외인+4.7억+4.7+0.0-0.1-4.6+0.0
2026-05-2928,35027,800🔵 -1.94%+0.00%p×0.8🟢 외인+2.0억+3.4-1.4-0.3-2.7+1.0
2026-05-2829,50028,350🔵 -3.90%-0.34%p×0.9⚫ 그외-0.4억-0.4+0.0+0.1-1.3+1.6
2026-05-2729,40029,500🔴 +0.34%+0.85%p×0.9🟢 외인+1.2억+1.2+0.0-0.7+0.2-0.7
2026-05-2630,05029,400🔵 -2.16%+0.17%p×0.7🔻 개인-8.4억-8.4+0.0-0.1+7.0+1.6
2026-05-2228,85030,050🔴 +4.16%+0.35%p×0.6🟢 외인+7.4억+5.9+1.5+0.0-7.3-0.1

일자별 사유 (최신 위)

2026-08-11

  • 사유: 통풍 신약 에파미뉴라드 글로벌 3상 성공, 내년 국내허가 추진
  • 섹터 컨텍스트: KOSPI:제약 (smart +1,430억)
  • 매크로 원인: 제약·바이오 개별 임상·허가 호재 잇따르며 급등 (통풍신약 3상 성공, 이상지질혈증제 허가 등) (높음)

2026-06-29

  • 사유: —
  • 섹터 컨텍스트: KOSPI:제약 (smart +895억)
  • 매크로 원인: 반도체 쏠림 차익실현 후 제약·바이오로 순환매 유입 + 국민성장펀드 기대·바이오USA 훈풍에 동반 급등 (보통)